{"id":"W2925184412","doi":"10.1016/j.euo.2019.02.007","title":"Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Ferring; Astellas Pharma Canada; Sanofi; Merck; Bayer","keywords":"Medicine; Prostate cancer; Radium-223; Denosumab; Zoledronic acid; Androgen deprivation therapy; Oncology; Abiraterone acetate; Cancer; Internal medicine; Abiraterone; Bone metastasis; Osteoporosis; Androgen receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009131834,0.0002961875,0.0004635745,0.0001460726,0.0004635068,0.00005789565,0.0002334611,0.00005288289,0.0004849265],"category_scores_gemma":[0.00009108965,0.0001926931,0.0001686284,0.0002126106,0.0002393802,0.00009408608,0.0000932213,0.0003206867,0.0002680778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005852001,"about_ca_system_score_gemma":0.0003654258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003450329,"about_ca_topic_score_gemma":0.0007089496,"domain_scores_codex":[0.9966294,0.001521182,0.000545155,0.0006185718,0.0001538306,0.0005319192],"domain_scores_gemma":[0.9981263,0.0007894606,0.0002760923,0.0005042432,0.0001283907,0.0001755531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02629499,0.009816087,0.05244362,0.0002256306,0.01171706,0.004022964,0.08305591,0.0020928,0.2335943,0.008802674,0.06604809,0.5018858],"study_design_scores_gemma":[0.0280415,0.0118451,0.04233953,0.0001567736,0.001236697,0.000195964,0.003993611,0.003011974,0.0006602363,0.0004422578,0.9074977,0.0005786417],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8199161,0.0208074,0.0009584737,0.09523265,0.00372915,0.009358292,0.0005921999,0.000443208,0.04896249],"genre_scores_gemma":[0.9834044,0.001664956,0.005380014,0.002199422,0.0006035001,0.0005723512,0.0008561905,0.0001163987,0.005202775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8414496,"threshold_uncertainty_score":0.7857797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06879219085183638,"score_gpt":0.359064597872905,"score_spread":0.2902724070210686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}